PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Anhui Zhifei Longcom Biopharmaceutical, Hefei, China.\', \'CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.\', \'National Institute for Food and Drug Control, Beijing, China.\', \'CAS Key Laboratory of Microbial Physiological and Metabolic Engineering, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.\', \'Chongqing Medleader Bio-Pharm, Chongqing, China.\', \'Beijing Keytech Statistical Technology, Beijing, China.\', \'Center of Infectious Disease, Beijing Ditan Hospital, Capital Medical University, Beijing, China.\', \'Hunan Provincial Center for Disease Control and Prevention, Changsha, China.\', \'The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.\', \'Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.\', \'Hunan Provincial Center for Disease Control and Prevention, Changsha, China. Electronic address: gldlj@hotmail.com.\', \'CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China. Electronic address: gaof@im.ac.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1473-3099(21)00127-410.1016/S1473-3099(21)00127-4
?:doi
?:hasPublicationType
?:journal
  • The Lancet. Infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 33773111
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33773111>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33773111>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all